Humana reported $145.7B of revenue over the trailing twelve months, +18% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $145.7B (to Q2 2026). Net income: $1.28B, trailing twelve months to Q2 2026. Free cash flow: $1.95B, trailing twelve months to Q2 2026. Operating margin: 1.6%, trailing twelve months to Q2 2026.

HUMHumana

Healthcare

$422.30+59% 1Y

$422.30

$162.8452 weeks$443.49

HUM as reported

Humana reported $145.7B of revenue over the trailing twelve months, +18% on the year before. 10 reported series are charted on this page, each one as filed.

$145.7B

Revenue, trailing twelve months · to Q2 2026 · +18% against the twelve months before

Net income: $1.28B
Net income · −19% year on year · trailing twelve months to Q2 2026
Free cash flow: $1.95B
Free cash flow · −20% year on year · trailing twelve months to Q2 2026
Operating margin: 1.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for HUM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$145.7B	+18%	Q2 2026
Net income	$1.28B	−19%	Q2 2026
EPS	$10.59	−19%	Q2 2026
Operating margin	1.6%	n/a	Q2 2026
Net margin	0.71%	n/a	Q2 2026
ROE	6.6%	n/a	Q2 2026
ROA	2.3%	n/a	Q2 2026
ROIC	22%	n/a	Q2 2026
Free cash flow	$1.95B	−20%	Q2 2026
P/E	39.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.